Nowadays, studies suggest the role of epigenetic modifiers in FSHD onset and expression, including the level of 4q35 methylation and/or mutations in SMCHD1 gene [5, 24]. Here, SMCHD1 is linked to facioscapulohumeral muscular dystrophy.